Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Daniel B. Levine

Of Counsel

New York +1 212 841 1203

English
  • About
  • Representative Matters
  • Credentials
  • About

    Dan Levine has advised clients in strategic and financial transactions, principally involving China, for nearly 15 years. He focuses his practice on inbound and outbound M&A, joint ventures, private equity and venture capital investments, and technology and licensing transactions.

    Dan represents clients in numerous industries, including life sciences, clean energy, and technology. He has extensive experience in China’s life sciences sector, where he:

    • represents pharma, biotech, device companies, investment funds, and “red-chip” companies in cross-border product acquisitions and divestitures, financings, joint ventures, collaborations, licensing transactions, and promotion and distribution agreements; and
    • provides strategic advice to companies confronting business, legal, and regulatory challenges to their operations in China.

    Dan also helps clients navigate both the national security review process administered by the Committee on Foreign Investment in the United States (CFIUS) and China’s outbound investment approval process.

    Dan’s pro bono work includes representing U.S. health care professionals and Chinese companies to procure and supply personal protective equipment from China to the United States during the COVID-19 pandemic.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters
    • Represented JW Therapeutics in its $105 million purchase of substantially all of the assets of Syracuse Biopharma, a spin-out of Eureka Therapeutics.
    • Represented a global pharma company in its formation of a Hong Kong joint venture with a leading Asia-based private equity firm.
    • Represented Hua Medtech in its sale to Genesis Medtech.
    • Represented a leading life sciences company in a corporate venture investment in a China-based diagnostics and testing business.
    • Represented LONGi Green Energy Technology Co. Ltd. in its acquisition of a Malaysian manufacturing facility from and commercial agreements with SunEdison.

    • Represented Origin Technologies Corporation, LLC in connection with its $1.8 billion bid for Affymetrix, Inc.
    • Represented Tencent Holdings in multiple minority strategic investments.
    • Represented AstraZeneca in a strategic alliance with WuXi Apptec, including an option to acquire a biologics manufacturing facility in Wuxi City.
    • Represented a leading global pharma company in an option to acquire, and a minority investment in, a China-based innovative and pharma company.
    • Represented Huadong Pharmaceutical in an exclusive license to develop, manufacture, and commercialize a diabetes product from vTv Therapeutics.
    • Represented Cathay Pacific in the negotiation of a long-term distribution agreement with a leading GDS.
    • Represented a specialty healthcare company in its licensing of marketing rights for OTC consumer drugs.
    • Represented Telular Corporation in its sale to Avista Capital Partners for $253 million.
    • Represented Illumina, Inc. in its acquisition of Verinata Health, Inc. for up to $450 million in upfront and contingent payments.
    • Represented MidFirst Bank in its acquisition of Presidential Financial Corporation from Harbert Private Equity and the Belfer family.
    • Represented One Equity Partners in its minority investment in Grupo Phoenix, a leading packaging company in the Americas.
    • Represented a leading private equity fund in the formation of the largest veterinary products company in the United States and the subsequent sale of the fund’s interest therein.
    • Represented a leading middle-market private equity fund in the initial and add-on acquisitions forming the largest integrated retail property services firm in North America.

    Areas of Expertise

  • Credentials
    Education
    • The University of Chicago Law School, J.D., 2005
        • MVP² Fellowship
    • Inter-University Program in Chinese Language Studies, 2002
    • Yale University, B.A., 1997
    Bar Admissions
    • New York
    Judicial Clerkship
    • Hon. Deborah L. Cook, U.S. Court of Appeals, Sixth Circuit, 2005 - 2006
    Languages
    • Mandarin
    Pro Bono
    • Assisted Dr. Sumanth Kaja and other Emergency Medicine Resident Physicians at Bellevue and NYU Langone Hospital to procure N95 respirators and other PPE from China.
    Accolades
    • New York Super Lawyers, Mergers & Acquisitions "Rising Star" (2013)
    Previous Experience
    • Bear, Stearns & Co., Inc., Financial Analytics and Structured Transactions Group and Corporate Finance Department (1997-2001)

    Areas of Expertise

News and Insights

Events